Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Aby J. Mathew

Evp & Chief Scientific Officer at Biolife Solutions Inc (BLFS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $65K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 5SEC BLFSBiolife Solutions Inc Sell Plan 529392,937 held (−0%) $20.74 $11K —
Jan 8SEC BLFSBiolife Solutions Inc Sell Plan 405349,350 held (−0%) $25.59 $10K —
Dec 17SEC BLFSBiolife Solutions Inc Sell Plan 631349,755 held (−0%) $25.13 $16K —
Nov 28SEC BLFSBiolife Solutions Inc Sell Plan 526350,386 held (−0%) $26.74 $14K —
Oct 14SEC BLFSBiolife Solutions Inc Sell Plan 509350,912 held (−0%) $27.36 $14K —
  • Sell

    Evp & Chief Scientific Officer Aby J. Mathew sold $11K of BLFS at $20.74 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Aby J. Mathew sold $10K of BLFS at $25.59 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Aby J. Mathew sold $16K of BLFS at $25.13 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Aby J. Mathew sold $14K of BLFS at $26.74 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Aby J. Mathew sold $14K of BLFS at $27.36 — pre-scheduled 10b5-1 plan sale.